Singapore markets closed

Straits Times Index
3,348.87
+12.28(+0.37%)
S&P 500
5,272.47
-5.04(-0.10%)
Dow
38,477.18
-209.14(-0.54%)
Nasdaq
16,792.63
+57.61(+0.34%)
Bitcoin USD
69,193.85
+1,104.34(+1.62%)
CMC Crypto 200
1,481.77
+13.84(+0.94%)

BMY Jan 2025 40.000 put

OPR - OPR Delayed price. Currency in USD

Add to watchlist

2.5200

-0.4500

(-15.15%)

As of 10:51AM EDT. Market open.

Business Wire
Bristol Myers Squibb’s Breyanzi Demonstrates Clinically Meaningful Outcomes Across Broad Range of B-Cell Malignancies in New Data Presented at 2024 ASCO® Annual Meeting
PRINCETON, N.J., June 03, 2024--BMS' Breyanzi Demonstrates Clinically Meaningful Outcomes Across Broad Range of B-Cell Malignancies in New Data Presented at 2024 ASCO® Annual Meeting
Business Wire
Bristol Myers Squibb Presents Multiple New Analyses at 2024 ASCO® Annual Meeting Highlighting Opdivo and Opdivo-based Combinations in Early and Advanced Stages of Non-Small Cell Lung Cancer
PRINCETON, N.J., June 03, 2024--Bristol Myers Squibb Presents Multiple New Analyses at 2024 ASCO® Annual Meeting Highlighting Opdivo and Opdivo-based Combinations...
Business Wire
KRAZATI (adagrasib) Demonstrated Statistically Significant Improvement in Progression-Free Survival in Patients with Pretreated Locally Advanced or Metastatic KRASG12C-Mutated Non-Small Cell Lung Cancer
PRINCETON, N.J., June 01, 2024--KRAZATI (adagrasib) Demonstrated Statistically Significant Improvement in Progression-Free Survival in Patients with Pretreated Locally Advanced....